Isaac Nichols, PharmD, on DOACs in the Management of New-Onset Venous Thromboembolism and Nonvalvular Atrial Fibrillation

In this podcast, Isaac Nichols, PharmD, speaks about the appropriateness of direct oral anticoagulation prescribing for new-onset venous thromboembolism and nonvalvular atrial fibrillation, specifically the Xa inhibitors, rivaroxaban and apixaban. He presented on this topic at ASHP Midyear 2021.

Additional Resource:

Isaac Nichols, PharmD, is a PGY1 pharmacy resident at Oklahoma State University Medical Center in Tulsa, Oklahoma.